Latest Methadone Stories
- Orexigen expects to end 2014 with approximately $190 million in cash, cash equivalents and marketable securities SAN DIEGO, Oct. 15, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.
PAINWeekEnd Irvine presents a full day of pain management CME and takes place on Saturday, October 25 at the Irvine Marriott. Montclair, NJ (PRWEB) October 14,
WEST HOLLYWOOD, Calif., Oct. 13, 2014 /PRNewswire-USNewswire/ -- Records show that Dr.
MobilenMB is the new, safe and side effect-free supplements that doesn’t just treat joint pain, but also starts healing and restoring the joints in as little as 7 days, faster than any other
Butrans® is now available for prescribing in five dosage strengths STAMFORD, Conn., Oct. 9, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced the U.S.
Position Statement Authored by American Academy of Clinical Toxicology, American College of Medical Toxicology and American Association of Poison Control Centers Alexandria,
Body chemistry analysis, diagnosis, and treatment now available to more patients through an expanded network of doctors, now also subsidized by many insurance programs FOSTER CITY,
Helping eligible opioid dependent patients in need MORRISTOWN, N.J., Oct. 7, 2014 /PRNewswire/ -- As part of our ongoing commitment to addiction medicine, Orexo US, Inc.
Conference Call Scheduled for Tuesday, October 7 at 8:00 AM Eastern Time RALEIGH, N.C., Oct. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc.
New white paper released as hydrocodone is reclassified as a Schedule II drug ITASCA, Ill., Oct.
- A bereavement by loss of parents or children; the state of being orbate; orbation.